These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 28709990)

  • 1. In-vitro development of an effective treatment for Acanthamoeba keratitis.
    Ortillés Á; Belloc J; Rubio E; Fernández MT; Benito M; Cristóbal JÁ; Calvo B; Goñi P
    Int J Antimicrob Agents; 2017 Sep; 50(3):325-333. PubMed ID: 28709990
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synergy Testing of Antiamoebic Agents for Acanthamoeba: Antagonistic Effect of Voriconazole.
    Talbott M; Cevallos V; Chen MC; Chin SA; Lalitha P; Seitzman GD; Lietman TM; Keenan JD
    Cornea; 2019 Oct; 38(10):1309-1313. PubMed ID: 31306283
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro evaluations of topical agents to treat Acanthamoeba keratitis.
    Sunada A; Kimura K; Nishi I; Toyokawa M; Ueda A; Sakata T; Suzuki T; Inoue Y; Ohashi Y; Asari S; Iwatani Y
    Ophthalmology; 2014 Oct; 121(10):2059-65. PubMed ID: 24880905
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Status of the effectiveness of contact lens disinfectants in Malaysia against keratitis-causing pathogens.
    Abjani F; Khan NA; Jung SY; Siddiqui R
    Exp Parasitol; 2017 Dec; 183():187-193. PubMed ID: 28919333
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acanthamoeba keratitis in Mexico: Report of a clinical case and importance of sensitivity assays for a better outcome.
    Omaña-Molina M; Vanzzini-Zago V; Hernández-Martínez D; Reyes-Batlle M; Castelan-Ramírez I; Hernández-Olmos P; Salazar-Villatoro L; González-Robles A; Ramírez-Flores E; Servín-Flores C; Flores-Alvarado V; Alcántara-Castro M; Lorenzo-Morales J
    Exp Parasitol; 2019 Jan; 196():22-27. PubMed ID: 30472333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the sensitivity to chlorhexidine, voriconazole and itraconazole of T4 genotype Acanthamoeba isolated from Mexico.
    Hernández-Martínez D; Reyes-Batlle M; Castelan-Ramírez I; Hernández-Olmos P; Vanzzini-Zago V; Ramírez-Flores E; Sifaoui I; Piñero JE; Lorenzo-Morales J; Omaña-Molina M
    Exp Parasitol; 2019 Feb; 197():29-35. PubMed ID: 30648558
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of povidone iodine, chlorhexidine digluconate and toyocamycin on amphizoic amoebic strains, infectious agents of
    Padzik M; Baltaza W; Conn DB; Szaflik JP; Chomicz L
    Ann Agric Environ Med; 2018 Dec; 25(4):725-731. PubMed ID: 30586959
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In Vitro Amoebicidal Activity of Titanium Dioxide/UV-A Combination Against Acanthamoeba.
    Gomart G; Denis J; Bourcier T; Dory A; Abou-Bacar A; Candolfi E; Sauer A
    Invest Ophthalmol Vis Sci; 2018 Sep; 59(11):4567-4571. PubMed ID: 30242357
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-Acanthamoeba synergistic effect of chlorhexidine and Garcinia mangostana extract or α-mangostin against Acanthamoeba triangularis trophozoite and cyst forms.
    Sangkanu S; Mitsuwan W; Mahabusarakam W; Jimoh TO; Wilairatana P; Girol AP; Verma AK; de Lourdes Pereira M; Rahmatullah M; Wiart C; Siyadatpanah A; Norouzi R; Mutombo PN; Nissapatorn V
    Sci Rep; 2021 Apr; 11(1):8053. PubMed ID: 33850179
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Weak cytotoxic activity of miltefosine against clinical isolates of Acanthamoeba spp.
    Mrva M; Garajová M; Lukáč M; Ondriska F
    J Parasitol; 2011 Jun; 97(3):538-40. PubMed ID: 21506779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of voriconazole anti-Acanthamoeba polyphaga in vitro activity, rat cornea penetration and efficacy against experimental rat Acanthamoeba keratitis.
    Gueudry J; Le Goff L; Compagnon P; Lefevre S; Colasse E; Aknine C; Duval F; François A; Razakandrainibe R; Ballet JJ; Muraine M; Favennec L
    J Antimicrob Chemother; 2018 Jul; 73(7):1895-1898. PubMed ID: 29596605
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of a practical complete-kill assay to evaluate anti-Acanthamoeba drugs.
    Kowalski RP; Abdel Aziz S; Romanowski EG; Shanks RM; Nau AC; Raju LV
    JAMA Ophthalmol; 2013 Nov; 131(11):1459-62. PubMed ID: 24077460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Successful medical therapy of Acanthamoeba keratitis with topical chlorhexidine and propamidine.
    Seal D; Hay J; Kirkness C; Morrell A; Booth A; Tullo A; Ridgway A; Armstrong M
    Eye (Lond); 1996; 10 ( Pt 4)():413-21. PubMed ID: 8944089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of In Vitro Antiamoebic Activity of Antimicrobial Agents Against Clinical Acanthamoeba Isolates.
    Nakaminami H; Tanuma K; Enomoto K; Yoshimura Y; Onuki T; Nihonyanagi S; Hamada Y; Noguchi N
    J Ocul Pharmacol Ther; 2017 Oct; 33(8):629-634. PubMed ID: 28704121
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The reculture technique: individualizing the treatment of Acanthamoeba keratitis.
    Wysenbeek YS; Blank-Porat D; Harizman N; Wygnanski-Jaffe T; Keller N; Avni I
    Cornea; 2000 Jul; 19(4):464-7. PubMed ID: 10928758
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytotoxic effect of acriflavine against clinical isolates of Acanthamoeba spp.
    Polat ZA; Karakus G
    Parasitol Res; 2013 Feb; 112(2):529-33. PubMed ID: 23052789
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug resistance and Acanthamoeba keratitis: the quest for alternative antiprotozoal chemotherapy.
    Hay J; Kirkness CM; Seal DV; Wright P
    Eye (Lond); 1994; 8 ( Pt 5)():555-63. PubMed ID: 7835453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the in vitro activity of commercially available moxifloxacin and voriconazole eye-drops against clinical strains of Acanthamoeba.
    Martín-Navarro CM; López-Arencibia A; Arnalich-Montiel F; Valladares B; Piñero JE; Lorenzo-Morales J
    Graefes Arch Clin Exp Ophthalmol; 2013 Sep; 251(9):2111-7. PubMed ID: 23686225
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Evaluation of in vitro efficacy of combined riboflavin and ultraviolet-A (365 nm) for Acanthamoeba].
    Letsch J; Abou-Bacar A; Candolfi E; Bourcier T; Sauer A
    J Fr Ophtalmol; 2015 Mar; 38(3):213-9. PubMed ID: 25637236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antimicrobial action of biguanides on the viability of Acanthamoeba cysts and assessment of cell toxicity.
    Mafra CS; Carrijo-Carvalho LC; Chudzinski-Tavassi AM; Taguchi FM; Foronda AS; Carvalho FR; de Freitas D
    Invest Ophthalmol Vis Sci; 2013 Sep; 54(9):6363-72. PubMed ID: 23900604
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.